+
Site Tour
CARDIOMEMS
HEART FAILURE (HF)
SYSTEM

For pulmonary artery pressure monitoring

PATIENT SELECTION AND ASSESSMENT

SELECTING THE RIGHT PATIENT

The CardioMEMS™ heart failure (HF) System is indicated for patients with:1

  • New York Heart Association (NYHA) Class Class III heart failure; and
  • One hear failure hospitalization in the past 12 months

THE CARDIOMEMS HF SYSTEM IS CONTRAINDICATED FOR PATIENTS WITH:

  • An inability to take dual antiplatelet or anticoagulants for one-month post implant

PATIENTS WHO MOST COMMONLY RECEIVE THE CARDIOMEMS HF SYSTEM ARE THOSE ON GDMT AND THOSE WHO EXHIBIT ANY OF THE FOLLOWING:1

  • Fluid volumes that are hard to know or manage
  • Challenging physical assessment
  • Is a patient with heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF)
  • Compliant with heart failure medical care
  • Would benefit from remote monitoring if they live far from a clinic

MEET
LESLIE:


 

I’m still here and
I’ll just keep going.
The people that
have heart failure
shouldn’t give up,
because it’s out
there. Just got to ask.

MEET
JUAN-ANTONIO:


 

Knowing that the
CardioMEMS HF
System detects a
problem a month in
advance gives me a
huge peace of mind

 

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

References
  1. Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M., Costanzo, M. R., Stevenson, L. W., …Yadav, J. S., for the CHAMPION Trial Study Group. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. The Lancet, 377(9766), 658-666. dx.doi.org/10.1016/S0140-6736(11)60101-3.

© Abbott 2023. All rights reserved. 9-EH-5-14466-01 08-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline